Acadia Healthcare Company, Inc. Share Price

Equities

ACHC

US00404A1097

Healthcare Facilities & Services

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
73.59 USD +0.29% Intraday chart for Acadia Healthcare Company, Inc. +4.89% -5.36%
Sales 2024 * 3.22B 258B Sales 2025 * 3.54B 283B Capitalization 6.8B 544B
Net income 2024 * 328M 26.26B Net income 2025 * 372M 29.78B EV / Sales 2024 * 2.63 x
Net Debt 2024 * 1.68B 135B Net Debt 2025 * 1.65B 132B EV / Sales 2025 * 2.39 x
P/E ratio 2024 *
20.8 x
P/E ratio 2025 *
18.5 x
Employees 20,250
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.1%
More Fundamentals * Assessed data
Dynamic Chart
North American Morning Briefing : Tech Still in -2- DJ
Deutsche Bank Upgrades Acadia Healthcare to Hold From Sell, Price Target is $70 MT
Acadia Healthcare Company, Inc. Announces Opening of its Newest Acute Care Hospital, Agave Ridge Behavioral Hospital, Located at 3322 S. Ellsworth Road, in Mesa, Arizona CI
Acadia Healthcare Appoints Stephanie Eken as Chief Medical Officer CI
Acadia Healthcare, Uber Collaborate to Provide Patients Access to Transportation MT
Acadia Healthcare Company, Inc. Accelerates Access to Care with Uber Health CI
Acadia Healthcare Completes 3 Comprehensive Treatment Centers Acquisition MT
Acadia Healthcare Company, Inc. acquired Comprehensive Treatment Center in Greenville, North Carolina. CI
Acadia Healthcare Company, Inc. acquired Comprehensive Treatment Center in Raleigh, North Carolina. CI
Tufts Medicine and Acadia Healthcare Company Break Ground on New Behavioral Health Hospital to Serve Greater Boston Area CI
Acadia Healthcare Company, Inc. acquired Comprehensive Treatment Centers in North Carolina. CI
Transcript : Acadia Healthcare Company, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:45 AM
Mizuho Securities Price Target on Acadia Healthcare to $84 From $77, Maintains Neutral Rating MT
Acadia Healthcare Company Seeks M&A CI
Transcript : Acadia Healthcare Company, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 10:25 AM
More news
1 day+0.29%
1 week+4.89%
Current month-7.11%
1 month-4.18%
3 months-12.58%
6 months+2.69%
Current year-5.36%
More quotes
1 week
69.91
Extreme 69.905
74.65
1 month
69.46
Extreme 69.46
80.03
Current year
69.46
Extreme 69.46
87.77
1 year
66.49
Extreme 66.49
87.77
3 years
50.07
Extreme 50.07
89.85
5 years
11.09
Extreme 11.09
89.85
10 years
11.09
Extreme 11.09
89.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 10/04/22
Director of Finance/CFO 51 09/07/23
Chief Tech/Sci/R&D Officer - 02/01/22
Members of the board TitleAgeSince
Director/Board Member 70 31/03/11
Director/Board Member 59 18/01/12
Director/Board Member 68 15/12/18
More insiders
Date Price Change Volume
26/04/24 73.59 +0.29% 689,372
25/04/24 73.38 +3.08% 1,103,907
24/04/24 71.19 +0.64% 454,423
23/04/24 70.74 +0.68% 539,126
22/04/24 70.26 +0.14% 581,688

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. Its facilities and services are classified into various categories: acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. It operates over 10 CTC locations in North Carolina and 160 locations in 32 states across the country. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates a network of over 253 behavioral healthcare facilities with 11,200 beds in 38 states and Puerto Rico.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
73.59 USD
Average target price
95.85 USD
Spread / Average Target
+30.24%
Consensus